| Dr Karen Elisabeth Lantz, MD | |
|
1743 Redstone Center Dr, Ste. 115, Park City, UT 84098-7929 | |
| (435) 658-9200 | |
| (435) 658-9210 |
| Full Name | Dr Karen Elisabeth Lantz |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1743 Redstone Center Dr, Park City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043300650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 5317761-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Elisabeth Lantz, MD Po Box 510708, Salt Lake City, UT 84151-0708 Ph: (801) 587-6600 | Dr Karen Elisabeth Lantz, MD 1743 Redstone Center Dr, Ste. 115, Park City, UT 84098-7929 Ph: (435) 658-9200 |
News Archive
"As a major international deadline on foreign assistance transparency draws closer, a new index shows that while donors are becoming more open with their data, still less than half of foreign aid information is openly available," Inter Press Service reports.
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.
Taunted, harassed, and pushed to a deadly breaking point. Last year, stories of teen bullying brought to life the heartbreaking consequences of young lives cut short by ruthless and unchecked behavior. While recent media coverage of these violent acts has increased national awareness of bullying's deadly consequences, it has done little to stop it from happening.
Electronic anti-theft systems still post a threat to cardiac device patients, according to research presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Professor Robert Stevenson, senior scientist at Greatbatch Medical in Santa Clarita, California, US.
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that Ruben Mesa, MD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 14, 2014 at the 19th Congress of European Hematology Association (EHA) which is being held in Milan, Italy, from June 12-15, 2014.
› Verified 3 days ago
Dr. Monica M Schaffer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 750 Round Valley Dr, Suite 102, Park City, UT 84060 Phone: 435-655-0926 Fax: 435-649-3748 | |
Eileen Gallagher, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1441 Ute Blvd Ste 220, Park City, UT 84098 Phone: 435-602-0187 Fax: 435-355-3734 | |
Katherine Rebecca Lavender, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 750 Round Valley Dr, Suite 102, Park City, UT 84060 Phone: 435-655-0926 Fax: 435-649-3748 | |
Laura Lynn Sells, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4000 Canyons Resort Dr, Park City, UT 84098 Phone: 435-615-2235 Fax: 435-645-7768 | |
Dr. Emil Chuang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2458 E Westview Trl, Park City, UT 84098 Phone: 760-815-7669 | |
Dr. Lena Sjoquist Terry, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 750 Round Valley Dr, Suite 102, Park City, UT 84060 Phone: 435-655-0926 Fax: 435-649-3748 |